Literature DB >> 24704424

MiR-612 suppresses the stemness of liver cancer via Wnt/β-catenin signaling.

Jun Tang1, Zhong-Hua Tao2, Duo Wen1, Jin-Liang Wan1, Dong-Li Liu1, Shu Zhang1, Jie-Feng Cui1, Hui-Chuan Sun1, Lu Wang1, Jian Zhou3, Jia Fan3, Wei-Zhong Wu4.   

Abstract

Previous research showed that microRNA-612 (miR-612) has inhibitory effects on cell proliferation, migration, invasion, and metastasis of hepatocellular carcinoma (HCC). AKT2 was confirmed to be a direct target of miR-612, through which the epithelial-mesenchymal transition (EMT) and metastasis of HCC were inhibited. Our present findings reveal that miR-612 is able to suppress the stemness of HCC by reducing the number and size of tumorspheres as well as clone formation in soft agar, and to relieve drug resistance to cisplatin and 5-fluorouracil. In addition, miR-612 hampered the capacity of tumorigenesis in NOD/SCID mice and redistributed the tumor invasive frontier of miR-612-modulating cells. Finally, our findings suggest that Wnt/β-catenin signaling is required in the regulation of EMT-associated stem cell-like traits by miR-612.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Hepatocellular carcinoma; Invasive frontier; Wnt/β-catenin; miR-612

Mesh:

Substances:

Year:  2014        PMID: 24704424     DOI: 10.1016/j.bbrc.2014.03.135

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  microRNA regulation of Wnt signaling pathways in development and disease.

Authors:  Jia L Song; Priya Nigam; Senel S Tektas; Erica Selva
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

Review 2.  MicroRNA regulation of liver cancer stem cells.

Authors:  Weiyang Lou; Jingxing Liu; Yanjia Gao; Guansheng Zhong; Bisha Ding; Liang Xu; Weimin Fan
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

3.  Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy.

Authors:  Minal Garg
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

4.  NFKB1-miR-612-FAIM2 pathway regulates tumorigenesis in neurofibromatosis type 1.

Authors:  Meng Wang; Zengtao Wang; Xiaolei Zhu; Shibing Guan; Zhibo Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-06-13       Impact factor: 2.416

5.  MicroRNA-497-5p attenuates IL-1β-induced cartilage matrix degradation in chondrocytes via Wnt/β-catenin signal pathway.

Authors:  Liying Hou; Hui Shi; Mingming Wang; Jinghua Liu; Guoqiang Liu
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

6.  Long non-coding RNA LINC00460 promotes head and neck squamous cell carcinoma cell progression by sponging miR-612 to up-regulate AKT2.

Authors:  Xiaoxing Xie; Gaoyun Xiong; Qingliang Wang; Yanping Ge; Xiaoying Cui
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

7.  MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.

Authors:  Qian Jiang; Miao He; Shu Guan; Mengtao Ma; Huizhe Wu; Zhaojin Yu; Longyang Jiang; Yan Wang; Xingyue Zong; Feng Jin; Minjie Wei
Journal:  Tumour Biol       Date:  2015-11-04

8.  Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.

Authors:  Heidrun Karlic; Roman Thaler; Christopher Gerner; Thomas Grunt; Katharina Proestling; Florian Haider; Franz Varga
Journal:  Cancer Genet       Date:  2015-03-18

9.  MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.

Authors:  Hong-Wei Hua; Feng Jiang; Qian Huang; Zhijun Liao; Gang Ding
Journal:  Oncotarget       Date:  2015-02-28

10.  The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.

Authors:  Rui Wang; Yumei Li; Yueyue Hou; Qingling Yang; Sulian Chen; Xi Wang; Zishu Wang; Yan Yang; Changjie Chen; Zhiwei Wang; Qiong Wu
Journal:  Oncotarget       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.